Arv­inas’ prostate can­cer treat­ment shows hints of sig­nal — but how many pa­tients will it work for?

3 years ago
R&D

FDA ac­cepts an­oth­er sBLA for Mer­ck­'s Keytru­da, fol­low­ing Imfinzi in bil­iary tract can­cer

3 years ago
FDA+

Sam­sung Bi­o­log­ics se­cures $400M+ man­u­fac­tur­ing deal with Pfiz­er

3 years ago
Deals
Manufacturing

4DMT's in­hal­able gene ther­a­py for cys­tic fi­bro­sis shows ear­ly pos­i­tive signs in tiny group of pa­tients

3 years ago
R&D
Cell/Gene Tx

Ak­ili re­leas­es non-pre­scrip­tion ver­sion of video game dig­i­tal ther­a­py for adults with AD­HD

3 years ago
R&D

Up­stream Bio match­es first fund­ing round with an­oth­er $200M to get asth­ma drug to PhI­II

3 years ago
Financing
Startups

Af­ter gene ther­a­py deaths, Astel­las to re­vis­it fa­tal neu­ro­mus­cu­lar con­di­tion in part­ner­ship with biotech start­up

3 years ago
Deals
R&D

Tiny biotech takes on mR­NA vac­cine jug­ger­nauts in fed­er­al court in patent in­fringe­ment cas­es

3 years ago
Pharma
Law

Eco­lab di­vi­sion Puro­lite will in­vest $190M to con­struct new resin pro­duc­tion fa­cil­i­ty

3 years ago
Manufacturing

FDA shuts down Intar­ci­a's re­quests to de­vi­ate from typ­i­cal post-CRL hear­ing process

3 years ago
Pharma

Health eq­ui­ty coali­tion led by AMA tags phar­ma part­ners for co­or­di­nat­ed ac­tion

3 years ago
Pharma
Marketing

Fo­s­un Phar­ma to re­ceive $100M+ via World Bank for fa­cil­i­ty in Ivory Coast

3 years ago
China
Pharma

FDA com­mis­sion­er says drug prices are too high, calls for bet­ter ev­i­dence gen­er­a­tion

3 years ago
Pharma
FDA+

Up­dat­ed: FDA sig­nals like­ly full ap­proval for Ei­sai's new Alzheimer's drug ahead of Fri­day's ad­comm

3 years ago
Pharma
FDA+

LNP biotech looks to go be­yond the liv­er, rais­ing $25M in seed mon­ey to move for­ward

3 years ago
Financing

Mozart Ther­a­peu­tics se­cures $25M ex­pan­sion to Se­ries A; Lian­Bio un­veils PhI­Ia da­ta for gas­tric can­cer treat­ment

3 years ago
News Briefing

Bit­ter­root Bio nabs $145M Se­ries A with a plan to tack­le chal­leng­ing can­cer tar­get for heart med­i­cines

3 years ago
Financing
Startups

Who pays the most (and least) in bio­phar­ma? We crunched me­di­an salary da­ta from 175 com­pa­nies

3 years ago
People

As­traZeneca, Sanofi's RSV an­ti­body set for FDA ad­comm on Thurs­day

3 years ago
Pharma
FDA+

Fi­bro­Gen grap­ples with PhI­II set­back in Duchenne mus­cu­lar dy­s­tro­phy

3 years ago
R&D

Day One goes to the mar­ket for $150M as biotech kicks off NDA re­quest for pe­di­atric brain can­cer drug

3 years ago
Financing
R&D

Co­gent Bio­sciences fol­lows AS­CO da­ta drop for KIT in­hibitor with up­sized $150M pub­lic stock of­fer­ing

3 years ago
Financing

Deer­field taps NYU Lan­gone Health as lat­est aca­d­e­m­ic part­ner, ink­ing $130M trans­la­tion­al re­search pact

3 years ago
Deals
Discovery

Bay­er gets its hands on Acuitas' LNP as it lines up first shots at gene edit­ing

3 years ago
Deals
Cell/Gene Tx
First page Previous page 330331332333334335336 Next page Last page
A service from the Financial Times